首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Repeated revascularization in patients with prior coronary bypass grafting: feasibility and outcome
【24h】

Repeated revascularization in patients with prior coronary bypass grafting: feasibility and outcome

机译:先前行冠状动脉搭桥术的患者再次血运重建的可行性和结果

获取原文
获取外文期刊封面目录资料

摘要

Native vessel (nv) atherosclerosis progression and bypass grafts (bg) degeneration limit the long-term outcome in patients with coronary bypass grafting (CABG). The study aimed to assess mechanisms of angina recurrence, feasibility and the long-term outcome in patients undergoing percutaneous revascularization (PCI). Material and methods: We studied 215 consecutive patients (80.9% men, mean age 62.8±8.1 y, range 40-82 y) with angina recurrence 92.9±48.8 months after CABG who underwent repeated coronary angiography. In patients referred for PCI, periprocedural troponin I (TnI) and MB fraction of creatine kinase (CK-MB) were evaluated. Results: In 186 patients we identified the reason for symptom recurrence: bg insufficiency in 38.6%, nv atherosclerosis progression in 23.3%, and both in 24.7%. PCI was attempted in 123 (66.1%) patients, and 5 (2.7%) were referred for CABG. PCI of bg was performed in 27.6% of patients, nv – in 61.0%, and both nv and bg in 11.4% (mean 1.4 lesions/patient). PCI was successful in 118 (95.9%) patients. During the periprocedural period there was 1 non fatal myocardial infarction (MI), and 1 intracranial hemorrhage following tissue plasminogen activator (tPA) administration. In the long term follow-up (FU) (mean 23.9±10.6 months, range 6–41 months), major cardiac events (MACE) occurred in 35 (29.7%) patients, including 5 (4.2%) deaths, 12 (10.2%) MIs, and 25 (21.2%) re-PCI. MACEs occurred in a higher proportion of patients after bg PCI than nv PCI (59% vs. 38%; p=0.014), and bg or nv PCI in the left anterior descending (LAD) artery territory as compared to other localizations (p=0.05). Both diagnosis of acute coronary syndrome at the time of PCI and postprocedural TnI, CK-MB increase significantly correlated with restenosis and MI in FU. Conclusions: Bg atherosclerosis is the leading cause of angina recurrence in patients with prior CABG; in 50% of patients there is also nv atherosclerosis progression. PCI is feasible in 2/3 of patients with angina recurrence after CABG. The bg and LAD territory PCI, and periprocedural TnI and CK-MB increase are related to higher cardiac event rate.
机译:天然血管(nv)的动脉粥样硬化进展和旁路移植(bg)变性限制了冠状动脉旁路移植(CABG)患者的长期结局。该研究旨在评估经皮血管重建术(PCI)患者心绞痛复发的机制,可行性和长期结果。材料和方法:我们研究了215例连续冠状动脉造影后CABG后92.9±48.8个月的心绞痛复发患者(男性80.9%,平均年龄62.8±8.1 y,范围40-82 y)。在接受PCI的患者中,评估了围手术期肌钙蛋白I(TnI)和肌酸激酶的MB分数(CK-MB)。结果:在186位患者中,我们确定了症状复发的原因:bg功能不全38.6%,nv动脉粥样硬化进展23.3%,两者均24.7%。 123例(66.1%)患者尝试了PCI,而CABG被转诊5例(2.7%)。 27.6%的患者行bg的PCI,nv – 61.0%的患者行nv和bg的11.4%的患者(平均1.4个病灶/患者)。 PCI在118例患者中成功(95.9%)。在围手术期,组织纤维蛋白溶酶原激活剂(tPA)给药后发生了1例非致命性心肌梗塞(MI)和1例颅内出血。在长期随访(FU)(平均23.9±10.6个月,范围6-41个月)中,发生重大心脏事件(MACE)的患者为35(29.7%),其中5例(4.2%)死亡,12例(10.2) %)MIs和25(21.2%)re-PCI。在发生bg PCI后,发生MACE的患者比例高于nv PCI(59%vs. 38%; p = 0.014),与其他局限性相比,左前降支(LAD)动脉区域的bg或nv PCI发生率更高(p = 0.05)。 PCI时的急性冠状动脉综合征诊断和术后TnI,CK-MB升高均与FU再狭窄和心肌梗死显着相关。结论:Bg动脉粥样硬化是先前CABG患者心绞痛复发的主要原因。在50%的患者中,还有n动脉粥样硬化进展。在CABG后2/3的心绞痛复发患者中,PCI是可行的。 bg和LAD领域的PCI,以及围手术期TnI和CK-MB的增加与更高的心脏事件发生率有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号